| |
|
|
|
Fennec Pharmaceuticals Inc  
|
|
8.09 -0.07 (-0.01%) |
01-25 16:00 |
|
Open: |
8.14 |
Pre close: |
8.16 |
Target:
|
9.57
|
|
High: |
8.19 |
Low: |
7.86 |
Resistance:
|
8.19
9.57
|
|
Volume: |
66,175 |
Market Cap: |
211M |
Support:
|
7.16
6.52
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.92
 |
MACD |
MACD(12,26):
|
0.10 |
|
MA(20): |
7.51 |
Signal(12,26,9): |
0.01 |
|
MA(100): |
7.23 |
Stochastic Oscillator |
%K(14,3):
|
89.46 |
|
MA(250): |
7.24 |
%D(3): |
83.53 |
|
Average Volume(K) |
3-Month: |
10391
|
52-Week |
High:
|
10.67 |
|
10-Days: |
8909 |
Low: |
4.65 |
|
RSI |
RSI(14):
|
60.71  |
Change(%): |
29.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.830 |
Return on Equity (ttm) |
-80.0 |
Shares Out. (M) |
25.81 |
|
EPS Est. Current Year |
-0.230 |
Return on Assets (ttm) |
-45.5 |
Shares Float (M) |
19.71 |
|
EPS Est. Next Year |
-0.210 |
PEG Ratio |
0.00 |
% Held by Insiders |
16.83 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
54.27 |
|
Forward EPS |
-0.520 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1050 |
|
Book Value (p.s.) |
1.210 |
EBITDA (p.s.) |
0.000 |
P/E |
-9.75 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.69 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.90 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-7.05 |
P/CF |
-15.02 |
|
|
|
|
|
|
